Replies to post #74867 on Muscle Pharm Corporation (MSLPQ)

[adamsapples]

What are you talking about? Here is massive revenue decrease the past 4 quarters. How is this pretty good?

Q1 2014 $50.2m

Q2 2014 $44.7m

Q3 2014 $41.1m

Q4 2014 $30.6m

I stripped out the minor revenue from BZNE as it was not applicable in Q1 numbers and stripped the bargain purchase gain on intangible assets that MSLP reported as revenue that is clearly not GAAP applicable.

We see a 40% decrease in revenue as net losses and expenses are exploding.

"pretty good' is really subjective but these facts are not arguable.

Here is the expense explosion over the same 4 quarters as revenues were cratering:

Q1 $14.3m

Q2 $15.3m

Q3 $18.7m

Q4 $22.9m

Now MLSP has supplier issues and was cut off during this quarter until a lump sum payment was issued that required a $4m loan. MSLP has borrowed more than $12m the last couple months just to stay afloat and has run out of cash again.

The cherry on top is Accounts Receivable and Inventory is way down and Accounts Payable is way up. The company is in dire dire straights.

The SEC investigation in not even close to being over. It is in high gear. Pyatt has been claiming the SEC Investigation is over for 18 months now and nothing has changed other than Pyatt lost his President title last year and now is going to lose his Chairman title this year. The SEC has made no comment.